Format

Send to

Choose Destination
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2198-204. doi: 10.2215/CJN.03630415. Epub 2015 Oct 1.

Long-Term Risk of Cancer in Survivors of Pediatric ESRD.

Author information

1
Department of Paediatric Nephrology, Emma Children's Hospital and.
2
Department of Paediatric Nephrology, Emma Children's Hospital and J.L.Vogelzang@amc.uva.nl.
3
Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands; and.
4
European Renal Association-European Dialysis and Transplant Association, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Abstract

BACKGROUND AND OBJECTIVES:

ESRD is associated with an increased risk of malignancies. We analyzed the incidence of cancer in patients with pediatric ESRD after long-term follow-up.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS:

All Dutch patients born before 1979 who were transplanted at age <15 years old in 1972-1992 were followed until 2010. We explored type and incidence of malignancies in patients compared with the general population using the National Cancer Registry.

RESULTS:

After a median of 25.3 years (1.3-37.8) of transplantation and at a median age of 33.5 years old (11.0-49.0), 105 primary malignancies had occurred in 54 of 249 patients. Among them, cutaneous squamous cell carcinoma was most frequent. Patients ages 25-30 years old had developed 16.5 times (95% confidence interval, 7.9 to 34.6) as many de novo tumors and 991 times (95% confidence interval, 313 to 3137) as many de novo cutaneous squamous cell carcinomas as their general population counterparts; in survivors ages 45-50 years old, these numbers were 81.5 (95% confidence interval, 50.7 to 131.1) and 2610 (95% confidence interval, 1596 to 4267), respectively. Cumulative incidence competing risk analysis showed that, after 30 years of transplantation, 41% of the survivors had developed cancer; 31% had developed a second de novo cancer <1 year after initial cancer diagnosis.

CONCLUSIONS:

Cancer is highly prevalent among patients with pediatric ESRD after 25.3 years of transplantation, with a high rate of recurrence.

KEYWORDS:

cancer; carcinoma; child; end-stage renal disease; follow-up studies; kidney failure, chronic; neoplasms; renal insufficiency, chronic; renal transplantation; squamous cell; survivors

PMID:
26430089
PMCID:
PMC4670765
DOI:
10.2215/CJN.03630415
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center